ClinicalTrials.govpublic full text
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
advanced solid tumor, esophageal cancer, metastatic solid tumor, non-small cell lung cancers, smarca4 gene mutation, advanced solid tumors, brg1, brm, metastatic solid tumors, nsclc, prt3789, pembrolizumab
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 811036
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.